+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Niacinamide Market by Application, Form, Distribution Channel, End User, Nature - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5613096
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Niacinamide Market grew from USD 745.60 million in 2024 to USD 782.66 million in 2025. It is expected to continue growing at a CAGR of 4.74%, reaching USD 984.60 million by 2030.

Niacinamide Market Overview and Strategic Imperatives

Niacinamide, a versatile form of vitamin B3, has emerged as a cornerstone ingredient across diverse industries due to its multifunctional benefits, ranging from skin health enhancement to nutritional fortification. In recent years, this compound has transcended its traditional use in pharmaceuticals to become a high-value additive in cosmetics, dietary supplements, animal feed, and food and beverage segments. The executive summary that follows distills the critical insights and strategic imperatives defining the current market landscape.

This introduction establishes the context for a comprehensive exploration of the trends reshaping industry dynamics. It highlights the importance of understanding the evolving regulatory environment, supply chain constraints, and shifting consumer preferences influencing demand for niacinamide. By examining transformative forces, tariff impacts, segmentation drivers, regional variations, and leading corporate strategies, stakeholders will gain a holistic perspective on opportunities and challenges.

The ensuing sections integrate market intelligence with actionable analysis, delivering a narrative that balances technical rigor with accessibility. Decision-makers and experts alike will find clear guidance on how to capitalize on emerging trends while mitigating risks. This summary serves as a strategic compass for navigating the niacinamide market with confidence and foresight.

Evolutionary Forces Redefining the Niacinamide Sector

The niacinamide landscape has undergone profound shifts driven by advancements in formulation technologies, evolving consumer wellness trends, and heightened sustainability concerns. Recent breakthroughs in encapsulation and delivery systems have enhanced bioavailability, enabling premium applications in anti-aging formulations, fortified food products, and performance-driven supplements. Simultaneously, the rise of clean-label preferences has prompted manufacturers to source vegetable-derived and yeast-derived niacinamide, aligning product portfolios with consumer expectations for natural origins.

Regulatory harmonization across key markets has streamlined approval pathways for new applications, but tightening impurity thresholds and traceability requirements have elevated compliance costs. These dynamics have spurred collaborations between ingredient suppliers, research institutions, and end users to develop cost-effective purification techniques and robust quality assurance protocols. The emergence of bio-synthetic routes further underscores the drive toward sustainable production.

Amid these technological and regulatory transformations, competitive differentiation hinges on rapid innovation cycles and transparent supply chain practices. As industry players navigate these shifts, those that proactively integrate scientific breakthroughs with responsible sourcing will secure a leading edge in the evolving niacinamide sector.

Assessing the Impact of 2025 US Tariffs on Niacinamide Trade

In 2025, the United States implemented revised tariff schedules that have material implications for the niacinamide trade. Import duties on feed-grade and pharmaceutical-grade vitamin B3 derivatives saw incremental hikes, altering cost structures for both upstream suppliers and downstream manufacturers. These changes have prompted a reassessment of sourcing strategies and price negotiation frameworks across the supply chain.

Domestic producers have gained a relative advantage as importers pass through tariff-induced price increases, leading to a modest reshoring of intermediate production capacities. However, reliance on petrochemical-sourced synthetic routes remains sensitive to global crude oil fluctuations, underscoring the need for diversified feedstock portfolios. Companies that anticipated the tariff adjustments and secured long-term contracts before their enforcement have managed to stabilize margins and protect end-user pricing.

Cross-border partnerships have also evolved, with collaborative ventures focusing on regional manufacturing hubs to circumvent tariff barriers. By establishing joint facilities in tariff-friendly jurisdictions, industry stakeholders are optimizing logistics and tapping into local incentives. As the market adapts to these geopolitical cost drivers, strategic alliances and flexible sourcing frameworks will be pivotal for sustaining competitive positioning.

Uncovering Critical Market Segmentation Dynamics

The niacinamide market’s diverse segmentation underscores the complexity of demand drivers and value chain strategies. Across application domains, Animal Feed’s aquaculture, cattle, poultry, and swine feed sectors prioritize cost-effective nutrient supplementation, whereas the Cosmetics arena leverages color cosmetics, hair care, and specialized skin care-spanning anti-aging, brightening, and moisturizing products-to address premium consumer expectations. In dietary supplements, formulations in capsules, liquids, powders, and tablets cater to varying convenience and bioavailability preferences, while the Food and Beverage segment incorporates niacinamide into bakery, confectionery, and dairy products for nutritional enrichment. Pharmaceutical applications split between over-the-counter remedies and prescription drugs, each governed by stringent regulatory standards.

Form-based analysis further refines market understanding by examining capsules, liquids, powders, and tablets as delivery formats that influence formulation complexity and processing requirements. Distribution channels reveal evolving purchasing behaviors: digital storefronts-both direct company websites and third-party platforms-compete with traditional brick-and-mortar outlets, including pharmacies, specialty shops, supermarkets, and hypermarkets. Each channel demands tailored marketing and logistics strategies.

End users such as feed manufacturers, food and beverage producers, personal care brands, and pharmaceutical companies shape procurement criteria based on product specifications and regulatory compliance. Finally, the nature of niacinamide-natural versus synthetic-determines raw material sourcing, with vegetable-derived, yeast-derived, bio-synthetic, and petrochemical-sourced variations impacting cost, purity, and sustainability credentials. This granular segmentation framework enables targeted strategy development and precise competitive benchmarking.

Regional Variations Shaping Niacinamide Demand

Regional insights reveal distinct growth trajectories driven by regulatory climates, consumer demographics, and manufacturing capabilities. In the Americas, robust demand is fueled by strong consumer awareness of nutraceutical benefits and established infrastructure for large-scale feed and pharmaceutical production. North American innovation hubs continue to introduce specialized skincare and dietary supplement formulations, reinforcing dominance in premium segments.

Europe, Middle East & Africa present a heterogeneous landscape where stringent EU regulatory frameworks coexist with emerging markets in the Gulf and Africa. While Western Europe leads in clean-label and natural-sourced niacinamide applications, markets in North Africa and the Middle East are accelerating adoption in fortified foods and animal nutrition, supported by government initiatives to bolster domestic agriculture.

Asia-Pacific remains the fastest-growing region, propelled by expanding middle-class populations and rising health consciousness. China and India serve as both major production centers-leveraging cost-competitive synthetic manufacturing-and rapidly expanding consumer markets for cosmetics and supplements. Southeast Asian countries are also emerging as strategic locations for new manufacturing investments, offering favorable incentives and proximity to key export destinations.

These regional variations underscore the importance of tailored go-to-market approaches and localized partnerships to capitalize on diverse demand drivers and regulatory environments.

Leading Players Steering Market Progress

Leading companies are driving innovation and consolidation within the niacinamide sector through product differentiation, strategic partnerships, and capacity expansions. Key players are investing in advanced purification technologies to meet the increasing demand for high-purity grades in pharmaceutical and personal care applications. These investments are often paired with joint development agreements that accelerate commercialization of novel encapsulation and delivery systems.

Several market leaders have strategically expanded their global footprint by establishing regional production facilities, thereby reducing lead times and mitigating tariff impacts. Collaborative ventures between multinational chemical corporations and specialty ingredient suppliers have emerged as a common approach to leverage complementary expertise and share capital expenditure risks. Meanwhile, established life sciences firms are strengthening their portfolios through targeted acquisitions of niche players specializing in natural and bio-synthetic vitamin B3 variants.

On the distribution front, top-tier producers are enhancing direct-to-consumer digital channels and forging preferred supplier agreements with large-scale feed and food manufacturers to secure long-term contracts. These alliances not only ensure stable demand but also facilitate co-innovation efforts. As competition intensifies, the ability to combine technical prowess with agile market access strategies is defining the new benchmark for leadership in the global niacinamide market.

Strategic Imperatives for Industry Advancement

Industry leaders should prioritize investment in sustainable production technologies to reduce reliance on petrochemical feedstocks and meet escalating regulatory and consumer demands for natural-sourced niacinamide. Establishing collaborations with biotechnology firms will accelerate the development of yeast-derived and bio-synthetic processes, enhancing both environmental credentials and supply resilience.

Expanding regional manufacturing capacity in tariff-advantaged jurisdictions can safeguard profitability and streamline logistics, particularly for high-volume animal feed and pharmaceutical segments. Companies must actively negotiate long-term supply agreements with raw material vendors, incorporating price stabilization mechanisms and flexibility clauses to navigate price volatility.

On the commercial front, fostering direct engagement with end users through co-creation initiatives will cement strategic partnerships and differentiate product offerings. Embracing digital transformation by optimizing e-commerce platforms and leveraging data analytics for demand forecasting will improve customer experience and inventory management. Integrating lifecycle assessments into product development and marketing communications will resonate with stakeholders increasingly focused on transparency and sustainability. By executing these targeted actions, industry leaders can secure competitive advantages and drive sustained growth in the evolving niacinamide market.

Robust Methodology Underpinning Research Rigor

This research employs a rigorous, multi-tiered methodology to ensure the integrity and reliability of findings. Primary data collection involved in-depth interviews with key stakeholders across the value chain, including ingredient suppliers, formulators, distributors, and end users in the pharmaceutical, personal care, food and feed industries. These qualitative insights were complemented by surveys gathering quantitative input on consumption patterns, price sensitivities, and product preferences.

Secondary research encompassed the review of regulatory documents, trade publications, patent filings, and company reports to construct a robust contextual foundation. Statistical databases and industry associations provided macroeconomic and trade flow data, which were triangulated against proprietary shipment records and customs data to validate trade dynamics and tariff impact analyses.

To enhance analytical rigor, advanced modeling techniques were applied to assess segmentation trends and regional demand trajectories. Data validation protocols, including cross-verification with third-party market intelligence platforms and peer reviews, were instituted to mitigate bias and ensure accuracy. This comprehensive approach underpins the strategic recommendations and insights presented throughout the report, delivering confidence in the robustness of the conclusions.

Conclusive Perspectives and Strategic Synopsis

In conclusion, the niacinamide market stands at an inflection point defined by technological innovation, supply chain realignment, and evolving regulatory landscapes. Stakeholders must navigate the complexities of tariff regimes, segmentation nuances, and regional growth differentials to capitalize on emerging opportunities. The integration of advanced purification and sustainable production methods will be critical to meeting the escalating demand for high-purity and naturally sourced variants.

Segment-specific strategies tailored to application requirements, form factors, distribution preferences, and end-user criteria will enable precise market positioning. Furthermore, proactive risk management through diversified sourcing and strategic partnerships will safeguard profitability amidst geopolitical and raw material uncertainties. Leading companies have already begun to set new performance benchmarks by aligning R&D investments with consumer and regulatory trends.

By synthesizing these insights, decision-makers are equipped with a clear, actionable framework for driving growth and innovation in the niacinamide sector. Continued vigilance in monitoring market shifts and a commitment to sustainable, agile practices will ensure resilience and leadership in this dynamic environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Animal Feed
      • Aquaculture Feed
      • Cattle Feed
      • Poultry Feed
      • Swine Feed
    • Cosmetics
      • Color Cosmetics
      • Hair Care
      • Skin Care
        • Anti-Aging
        • Brightening
        • Moisturizing
    • Dietary Supplements
      • Capsules
      • Liquid
      • Powder
      • Tablets
    • Food And Beverage
      • Bakery
      • Confectionery
      • Dairy
    • Pharmaceuticals
      • Over-The-Counter Drugs
      • Prescription Drugs
  • Form
    • Capsules
    • Liquid
    • Powder
    • Tablets
  • Distribution Channel
    • E-Commerce
      • Company Website
      • Third-Party Platforms
    • Offline Retail
      • Pharmacies And Drug Stores
      • Specialty Stores
      • Supermarkets And Hypermarkets
  • End User
    • Feed Manufacturers
    • Food And Beverage Manufacturers
    • Personal Care Manufacturers
    • Pharmaceutical Manufacturers
  • Nature
    • Natural
      • Vegetable-Derived
      • Yeast-Derived
    • Synthetic
      • Bio-Synthetic
      • Petrochemical-Sourced
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • BASF SE
  • Merck KGaA
  • Roquette Frères
  • Zhejiang Medicine Co., Ltd.
  • Hefei TNJ Chemical Co., Ltd.
  • Wuhan Grand Harvest Biotech Co., Ltd.
  • Shandong Pharmaceutical Group Co., Ltd.
  • Shanghai Lixin Biochemical Technology Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Niacinamide Market, by Application
8.1. Introduction
8.2. Animal Feed
8.2.1. Aquaculture Feed
8.2.2. Cattle Feed
8.2.3. Poultry Feed
8.2.4. Swine Feed
8.3. Cosmetics
8.3.1. Color Cosmetics
8.3.2. Hair Care
8.3.3. Skin Care
8.3.3.1. Anti-Aging
8.3.3.2. Brightening
8.3.3.3. Moisturizing
8.4. Dietary Supplements
8.4.1. Capsules
8.4.2. Liquid
8.4.3. Powder
8.4.4. Tablets
8.5. Food and Beverage
8.5.1. Bakery
8.5.2. Confectionery
8.5.3. Dairy
8.6. Pharmaceuticals
8.6.1. Over-The-Counter Drugs
8.6.2. Prescription Drugs
9. Niacinamide Market, by Form
9.1. Introduction
9.2. Capsules
9.3. Liquid
9.4. Powder
9.5. Tablets
10. Niacinamide Market, by Distribution Channel
10.1. Introduction
10.2. E-Commerce
10.2.1. Company Website
10.2.2. Third-Party Platforms
10.3. Offline Retail
10.3.1. Pharmacies and Drug Stores
10.3.2. Specialty Stores
10.3.3. Supermarkets and Hypermarkets
11. Niacinamide Market, by End User
11.1. Introduction
11.2. Feed Manufacturers
11.3. Food and Beverage Manufacturers
11.4. Personal Care Manufacturers
11.5. Pharmaceutical Manufacturers
12. Niacinamide Market, by Nature
12.1. Introduction
12.2. Natural
12.2.1. Vegetable-Derived
12.2.2. Yeast-Derived
12.3. Synthetic
12.3.1. Bio-Synthetic
12.3.2. Petrochemical-Sourced
13. Americas Niacinamide Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Niacinamide Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Niacinamide Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Koninklijke DSM N.V.
16.3.2. Lonza Group AG
16.3.3. BASF SE
16.3.4. Merck KGaA
16.3.5. Roquette Frères
16.3.6. Zhejiang Medicine Co., Ltd.
16.3.7. Hefei TNJ Chemical Co., Ltd.
16.3.8. Wuhan Grand Harvest Biotech Co., Ltd.
16.3.9. Shandong Pharmaceutical Group Co., Ltd.
16.3.10. Shanghai Lixin Biochemical Technology Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NIACINAMIDE MARKET MULTI-CURRENCY
FIGURE 2. NIACINAMIDE MARKET MULTI-LANGUAGE
FIGURE 3. NIACINAMIDE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 98. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 100. CANADA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 101. CANADA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 102. CANADA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 103. CANADA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 104. CANADA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 105. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. CANADA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. CANADA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 108. CANADA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 109. CANADA NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. CANADA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 111. CANADA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 112. CANADA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 113. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 115. MEXICO NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 121. MEXICO NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. MEXICO NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 124. MEXICO NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. MEXICO NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 127. MEXICO NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 189. GERMANY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. GERMANY NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 191. GERMANY NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 195. GERMANY NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. GERMANY NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. GERMANY NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 199. GERMANY NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 200. GERMANY NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. GERMANY NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 202. GERMANY NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 203. GERMANY NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 204. FRANCE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 206. FRANCE NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. FRANCE NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. FRANCE NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 214. FRANCE NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 215. FRANCE NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. FRANCE NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 217. FRANCE NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 218. FRANCE NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 234. ITALY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. ITALY NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 236. ITALY NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 237. ITALY NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 238. ITALY NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 239. ITALY NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 240. ITALY NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 241. ITALY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. ITALY NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ITALY NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 244. ITALY NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 245. ITALY NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. ITALY NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 247. ITALY NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 248. ITALY NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 249. SPAIN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SPAIN NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 251. SPAIN NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 257. SPAIN NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SPAIN NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 259. SPAIN NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 260. SPAIN NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SPAIN NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 262. SPAIN NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 263. SPAIN NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 309. DENMARK NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. DENMARK NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 311. DENMARK NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 312. DENMARK NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 313. DENMARK NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 314. DENMARK NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 315. DENMARK NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 316. DENMARK NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 317. DENMARK NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. DENMARK NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 319. DENMARK NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 320. DENMARK NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. DENMARK NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 322. DENMARK NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 323. DENMARK NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 339. QATAR NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. QATAR NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 341. QATAR NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 342. QATAR NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 343. QATAR NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 344. QATAR NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 345. QATAR NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 346. QATAR NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 347. QATAR NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. QATAR NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 349. QATAR NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 350. QATAR NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. QATAR NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 352. QATAR NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 353. QATAR NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 354. FINLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 355. FINLAND NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 356. FINLAND NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 357. FINLAND NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 358. FINLAND NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 359. FINLAND NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 360. FINLAND NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 361. FINLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 362. FINLAND NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 363. FINLAND NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 364. FINLAND NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 365. FINLAND NIACINAMIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 366. FINLAND NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
TABLE 367. FINLAND NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 368. FINLAND NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 369. SWEDEN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 370. SWEDEN NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 371. SWEDEN NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 372. SWEDEN NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 373. SWEDEN NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 374. SWEDEN NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2030 (USD MILLION)
TABLE 375. SWEDEN NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)

Companies Mentioned

The companies profiled in this Niacinamide market report include:
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • BASF SE
  • Merck KGaA
  • Roquette Frères
  • Zhejiang Medicine Co., Ltd.
  • Hefei TNJ Chemical Co., Ltd.
  • Wuhan Grand Harvest Biotech Co., Ltd.
  • Shandong Pharmaceutical Group Co., Ltd.
  • Shanghai Lixin Biochemical Technology Co., Ltd.

Methodology

Loading
LOADING...

Table Information